Symptoms and Severity of COVID-19 in Patients with Immune-Mediated Inflammatory Diseases: Experience of a University Medical Center

Table 1

Patient distribution of rheumatic and inflammatory bowel diseases.

Characteristic	No.	%
Total	156	100
Inflammatory bowel disease	117	75.0
Crohn’s disease	69	44.2
Ulcerative colitis	48	30.8
Rheumatic disease	39	25.0
Rheumatoid arthritis	13	8.3
Axial spondyloarthritis	9	5.8
Systemic lupus erythematosus	6	3.8
Psoriatic arthritis	6	3.8
Granulomatosis with polyangiitis	2	1.3
Sjögren’s syndrome	1	0.6
Juvenile idiopathic arthritis	1	0.6
Dermatomyositis/polymyositis	1	0.6